20140220 Conferinta Presa Cegedim-Arpim-Apmgr
15
Piața farmaceutică din România: rezultate 2013 și perspective 2014 20 februarie 2014
Transcript of 20140220 Conferinta Presa Cegedim-Arpim-Apmgr
Piața farmaceutică din România: rezultate 2013 și perspective 201420 februarie 2014
This document should not be distributed without Cegedim authorization – Copyright 2011
2
Agenda Rezultate 2013 Perspective 2014 Intrebări şi răspunsuri
3This document should not be distributed without Cegedim authorization – Copyright 2011
01 Rezultate 2013
This document should not be distributed without Cegedim authorization – Copyright 2011
4
Rezultate trim.4
Canal/ Segment
VOLUM ZILE DE TRATAMENT VALOARE PPP
Cota Piaţă
Variație
Cota Piaţă
Variație
Cota Piaţă
RON
EUR
(%) (+/- %) (%) (+/- %) (%) mil. RON (+/- %) mil. EUR (+/- %) Total piaţă 100,0 -3,6 100,0 -1,1 100,0 3.055,8 -2,4 686,4 -0,8
Retail 95,1 -3,6 97,8 -0,9 86,2 2.634,1 -2,8 591,7 -1,2
- Rx 65,8 -4,4 85,9 -0,9 81,2 2.139,1 -4,2 480,5 -2,7
- OTC 34,2 -2,1 14,1 -0,7 18,8 495,0 4,0 111,2 5,7
Spital 4,9 -3,1 2,2 -9,3 13,8 421,7 0,3 94,7 1,9
This document should not be distributed without Cegedim authorization – Copyright 2011
5
Rezultate 2013
Canal/ Segment
VOLUM ZILE DE TRATAMENT VALOARE PPP
Cota Piaţă
Variație
Cota Piaţă
Variație
Cota Piaţă
RON
EUR
(%) (+/- %) (%) (+/- %) (%) mil. RON (+/- %) mil. EUR (+/- %) Total piaţă 100,0 -1,1 100,0 0,2 100,0 11.748,9 0,3 2.658,9 1,1
Retail 95,1 -1.0 97,8 0,4 86,6 10.168,8 0,4 2.301,3 1,3
- Rx 67,6 -1,3 86,5 0,6 82,5 8.388,9 -0,8 1.898,5 0,1
- OTC 32,4 -0,2 13,5 -0,6 17,5 1.779,8 6,5 402,8 7,4
Spital 4,9 -3,1 2,2 -6,4 13,4 1.580,2 -0,5 357,6 0,4
This document should not be distributed without Cegedim authorization – Copyright 2011
6
Principalele grupe terapeutice (ATC1)
Grupe ATC1
VOLUM PREŢ MEDIU VALOARE PPP
mil. cutii
Cota de piaţă (%)
Variaţie (+/- %)
RON
mil. RON
Cota de piaţă (%)
Variaţie (+/- %)
Total 505,8 100.0 -1,1 23,2 11.748,9 100.0 0,3
Top grupe ATC1 436,2 86,2 -0,9 23,1 10.056,7 85,6 1,4
C - Sistem Cardiovascular 122,5 24,2 1,2 17,3 2.115,5 18.0 -0,2
L - Antineoplazice si Imunomodulatoare 3,1 0,6 9,8 662,7 2.040,7 17,4 7,7
A - Sistem Digestiv si Metabolism 93,8 18,5 -1,5 18,9 1.775,0 15,1 4,5
N - Sistem Nervos 81,4 16,1 -2,4 18,8 1.533,6 13,1 -2,4
J - Anti-infecțioase Sistemice 40,3 8.0 -4,8 29,5 1.188,3 10,1 -0,7
R - Sistem Respirator 54,9 10,9 0,1 15.0 823,7 7.0 -2,4
M – Sistem musculo-scheletic 40,2 7,9 -1.0 14,4 579,9 4,9 -2,7
Alte grupe ATC1 69,6 13,8 -2.0 24,3 1.692,3 14,4 -5,6
This document should not be distributed without Cegedim authorization – Copyright 2011
7
Top 20 CorporațiiNr.
Corporaţie
Trim. 4 2013
2013
∆ Trim.3 2013
(mil. RON) (mil. RON) (%) Total piaţă 3.055,8 11.748,9 100,0
1 HOFFMANN LA ROCHE 214,6 860,1 7,3 +1 2 SANOFI1 213,1 827,5 7.0 -1 3 NOVARTIS2 175,7 697,3 5,9 = 4 SERVIER3 173,6 677,7 5,8 = 5 PFIZER4 151,8 604,4 5,1 = 6 GLAXOSMITHKLINE5 143,7 552,6 4,7 = 7 MERCK & CO6 113,3 468,9 4.0 = 8 RANBAXY7 121.0 453,5 3,9 +1 9 ASTRAZENECA 113,9 444,2 3,8 -1 10 KRKA 80,8 311,8 2,7 = Subtotal Top 10 1.501,5 5.897,9 50,2 11 ANTIBIOTICE 74,7 295,6 2,5 = 12 JOHNSON & JOHNSON8 76,2 288,2 2,5 = 13 TEVA 69,6 272,3 2,3 = 14 ABBVIE 71,1 263,7 2,2 = 15 MENARINI 66,2 253.0 2,2 = 16 BRISTOL MYERS SQUIBB 56,6 227,2 1,9 = 17 BAYER HEALTHCARE AG9 60,1 223.0 1,9 +1 18 ALVOGEN 53,4 213,6 1,8 -1 19 ABBOTT10 46,6 185,4 1,6 = 20 ELI LILLY 47,1 185.0 1,6 = Subtotal Top 20 2.123,1 8.304,7 70,7
8This document should not be distributed without Cegedim authorization – Copyright 2011
02 Perspective 2014
This document should not be distributed without Cegedim authorization – Copyright 2011
9
Primele 20 grupe terapeutice (ATC3)
mil. RON Growth mil. RON Growth1 L1X (ALL OTHER ANTINEOPLASTIC) 1,041.5 21.0% 712.3 9.9%2 L4B (ANTI-TNF PRODUCTS) 470.3 18.4% 440.1 24.2%3 N5A (ANTIPSYCHOTICS) 468.2 10.7% 333.6 -12.3%4 C10A (CHOLESTEROL AND TRIGLYCERIDE REGULATING PREPARATIONS) 425.7 5.8% 339.3 -7.2%5 A10C (HUMAN INSULINS AND ANALOGUES) 413.4 13.2% 365.4 1.1%6 J5C (HIV ANTIVIRALS) 387.8 3.6% 286.5 -2.2%7 L3B (INTERFERONS) 383.0 4.9% 314.4 7.3%8 M1A (ANTI-RHEUMATICS, NON-STEROIDAL) 348.5 7.4% 292.5 -1.3%9 N2B (NON-NARCOTICS AND ANTI-PYRETICS) 318.1 12.1% 266.2 -1.5%10 C9A (ACE INHIBITORS, PLAIN) 279.4 1.6% 251.0 -3.6%11 A2B (ANTIULCERANTS) 245.7 10.8% 218.0 5.3%12 C4A (CEREBRAL AND PERIPHERAL VASOTHERAPEUTICS) 229.6 -4.2% 210.2 -7.0%13 B1C (PLATELET AGGREGATION INHIBITORS) 226.7 -9.7% 192.4 -17.2%14 R5A (COLD PREPARATIONS WITHOUT ANTI-INFECTIVES) 220.5 9.1% 177.5 7.9%15 N4A (ANTI-PARKINSON DRUGS) 217.9 22.8% 208.9 15.6%16 C7A (BETA-BLOCKING AGENTS, PLAIN) 206.6 10.0% 182.1 3.0%17 J5B (ANTIVIRALS, EXCLUDING ANTI-HIV PRODUCTS) 198.2 26.2% 159.2 7.5%18 J1D (CEPHALOSPORINS) 197.0 10.5% 175.4 0.4%19 C1D (CORONARY THERAPY EXCLUDING CALCIUM ANTAGONISTS AND NITRITES) 191.2 0.5% 172.8 -4.1%20 J1C (BROAD SPECTRUM PENICILLINS) 190.4 5.4% 156.8 -5.4%Subtotal Top 20 ATC3 6,659.7 10.0% 5,454.5 1.4%
Secondary Sales Tertiary SalesATC3 Group
This document should not be distributed without Cegedim authorization – Copyright 2011
10
Evoluție pe intervale valorice
Pret en-gros % Var % Var
2013 2012.0 2013.0 2012 2013 2013 2,012.0 2,013.0 2012 2013 2013
0: n/a 1.0 0.0 0.3% 0.0% -100.0% 26.5 0.0 0.3% 0.0% -100.0%
1: <10 RON 179.5 173.2 50.7% 49.6% -3.5% 933.5 905.2 9.3% 9.1% -3.0%
2: 10-25 RON 107.3 108.2 30.3% 31.0% 0.8% 1,760.6 1,740.4 17.5% 17.5% -1.1%
3: 25-100 RON 53.5 55.5 15.1% 15.9% 3.7% 2,513.8 2,460.9 25.1% 24.7% -2.1%
4: 100-250 RON 8.5 8.2 2.4% 2.4% -3.6% 1,307.5 1,241.7 13.0% 12.5% -5.0%
5: 250-1.000 RON 2.9 2.8 0.8% 0.8% -3.2% 1,364.6 1,327.0 13.6% 13.3% -2.7%
6: >1.000 RON 0.9 0.9 0.3% 0.3% 1.7% 2,125.8 2,282.6 21.2% 22.9% 7.4%
Total 353.8 348.8 100.0% 100.0% -1.4% 10,032.2 9,957.9 100.0% 100.0% -0.7%
Unitati (mil.) % Pondere Valoare (mil. RON) % Pondere
This document should not be distributed without Cegedim authorization – Copyright 2011
11
Disponibilitate alternative terapeutice
Nivel Subcategorie 2012 2013Produse noi 469 452Produse existente 3,415 3,606Produse disponibile 3,884 4,058Produse iesite 346 284Brand-uri noi 217 203Brand-uri existente 1,851 1,936Brand-uri disponibile 2,068 2,139Brand-uri iesite 156 135DCI/combinatii noi 51 37DCI/combinatii existente 886 882DCI/combinatii disponibile 937 919DCI/combinatii iesite 33 53
DCI
Brand
Produs
This document should not be distributed without Cegedim authorization – Copyright 2011
12
Perspective 2014
Rata de Crestere Medie Compusa (CAGR) = 4,8%
% Evolutie 2013 Prognoza
2013 Rezultat 2014 2015 2016 2017 2018
Total Piata 0.7% 0.3% 2.7% 5.3% 6.9% 6.3% 3.3% Retail 1.3% 0.4% 2.9% 5.5% 6.6% 5.8% 3.0% Rx 0.2% -0.8% 2.5% 7.1% 6.5% 5.4% 2.6% OTC 6.6% 6.5% 4.8% -1.8% 7.1% 7.8% 5.0%Spital -2.9% -0.5% 1.5% 4.1% 8.9% 9.3% 5.3%
13This document should not be distributed without Cegedim authorization – Copyright 2011
03 Intrebări şi răspunsuri
This document should not be distributed without Cegedim authorization – Copyright 2011
14
Intrebări şi răspunsuri
Acum e rândul dvs…
